Literature DB >> 16537268

Brain atrophy and cognitive impairment in survivors of Acute Respiratory Distress Syndrome.

Ramona O Hopkins1, Shawn D Gale, Lindell K Weaver.   

Abstract

PRIMARY
OBJECTIVES: Acute Respiratory Distress Syndrome (ARDS) is characterized by severe acute lung injury, hypoxemia and is associated with neurological and cognitive impairments. This study assessed quantitative brain and ventricular volumes in survivors of ARDS with brain computed tomography (CT) scans compared to normal controls. It also compared the medical and cognitive outcome data of patients with ARDS with and without CT scans. RESEARCH
DESIGN: Observational cohort study.
METHODS: Sixty-six consecutive acute respiratory distress patients, of which 15 patients with ARDS underwent brain CT and 51 patients had no brain imaging. Brain CT scans from 15 survivors of ARDS were compared to age- and sex-matched normal controls. Clinical radiological findings and ventricular volumes, brain volume and generalized brain atrophy.
RESULTS: The patients with ARDS and brain imaging had cognitive impairments, significant brain atrophy, ventricular enlargement and 53% had atrophy or lesions by radiological report.
CONCLUSIONS: Clinicians need to be aware that ARDS can cause significant long-term brain-related morbidity manifest by brain atrophy, lesions and neurocognitive impairments.

Entities:  

Mesh:

Year:  2006        PMID: 16537268     DOI: 10.1080/02699050500488199

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  41 in total

1.  Cognitive decline after hospitalization in a community population of older persons.

Authors:  R S Wilson; L E Hebert; P A Scherr; X Dong; S E Leurgens; D A Evans
Journal:  Neurology       Date:  2012-03-21       Impact factor: 9.910

2.  Can we optimize long-term outcomes in acute respiratory distress syndrome by targeting normoxemia?

Authors:  Mark E Mikkelsen; Brian Anderson; Jason D Christie; Ramona O Hopkins; Paul N Lanken
Journal:  Ann Am Thorac Soc       Date:  2014-05

3.  Neurologic complications during V-V extracorporeal membrane oxygenation: still counting….

Authors:  Federico Pappalardo; Andrea Montisci
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

Review 4.  Adjunctive therapies during veno-venous extracorporeal membrane oxygenation.

Authors:  Federico Pappalardo; Andrea Montisci
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

5.  Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation.

Authors:  Jeffrey J Lochhead; Gwen McCaffrey; Colleen E Quigley; Jessica Finch; Kristin M DeMarco; Nicole Nametz; Thomas P Davis
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-17       Impact factor: 6.200

Review 6.  Neuroimaging after critical illness: implications for neurorehabilitation outcome.

Authors:  Ramona O Hopkins; James C Jackson
Journal:  NeuroRehabilitation       Date:  2012       Impact factor: 2.138

7.  Functional brain imaging in survivors of critical illness: A prospective feasibility study and exploration of the association between delirium and brain activation patterns.

Authors:  James C Jackson; Alessandro Morandi; Timothy D Girard; Kristen Merkle; Amy J Graves; Jennifer L Thompson; Ayumi K Shintani; Max L Gunther; Christopher J Cannistraci; Baxter P Rogers; John C Gore; Hillary J Warrington; E Wesley Ely; Ramona O Hopkins
Journal:  J Crit Care       Date:  2015-01-30       Impact factor: 3.425

8.  Association of hospitalization with long-term cognitive and brain MRI changes in the ARIC cohort.

Authors:  Charles H Brown; A Richey Sharrett; Josef Coresh; Andrea L C Schneider; Alvaro Alonso; David S Knopman; Thomas H Mosley; Rebecca F Gottesman
Journal:  Neurology       Date:  2015-03-11       Impact factor: 9.910

Review 9.  SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation.

Authors:  Kiandokht Keyhanian; Raffaella Pizzolato Umeton; Babak Mohit; Vahid Davoudi; Fatemeh Hajighasemi; Mehdi Ghasemi
Journal:  J Neuroimmunol       Date:  2020-11-07       Impact factor: 3.478

Review 10.  Targeted drug delivery to treat pain and cerebral hypoxia.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Pharmacol Rev       Date:  2013-01-23       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.